421 related articles for article (PubMed ID: 20565769)
1. The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Najar M; Piccart M; Ghanem G; Body JJ; Journé F
BMC Cancer; 2010 Jun; 10():298. PubMed ID: 20565769
[TBL] [Abstract][Full Text] [Related]
2. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts.
Lee YC; Huang CF; Murshed M; Chu K; Araujo JC; Ye X; deCrombrugghe B; Yu-Lee LY; Gallick GE; Lin SH
Oncogene; 2010 Jun; 29(22):3196-207. PubMed ID: 20228840
[TBL] [Abstract][Full Text] [Related]
3. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
Garcia-Gomez A; Ocio EM; Crusoe E; Santamaria C; Hernández-Campo P; Blanco JF; Sanchez-Guijo FM; Hernández-Iglesias T; Briñón JG; Fisac-Herrero RM; Lee FY; Pandiella A; San Miguel JF; Garayoa M
PLoS One; 2012; 7(4):e34914. PubMed ID: 22539950
[TBL] [Abstract][Full Text] [Related]
5. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2.
Mostafa NZ; Fitzsimmons R; Major PW; Adesida A; Jomha N; Jiang H; Uludağ H
Connect Tissue Res; 2012; 53(2):117-31. PubMed ID: 21966879
[TBL] [Abstract][Full Text] [Related]
7. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
9. Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
Araujo JC; Poblenz A; Corn P; Parikh NU; Starbuck MW; Thompson JT; Lee F; Logothetis CJ; Darnay BG
Cancer Biol Ther; 2009 Nov; 8(22):2153-9. PubMed ID: 19855158
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
11. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
12. The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.
Park JB
J Surg Res; 2012 Mar; 173(1):99-104. PubMed ID: 21035140
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells.
Borriello A; Caldarelli I; Basile MA; Bencivenga D; Tramontano A; Perrotta S; Della Ragione F; Oliva A
PLoS One; 2011; 6(12):e28555. PubMed ID: 22164306
[TBL] [Abstract][Full Text] [Related]
14. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts.
Igarashi M; Kamiya N; Hasegawa M; Kasuya T; Takahashi T; Takagi M
J Mol Histol; 2004 Jan; 35(1):3-10. PubMed ID: 15323344
[TBL] [Abstract][Full Text] [Related]
15. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
[TBL] [Abstract][Full Text] [Related]
16. Anagliptin stimulates osteoblastic cell differentiation and mineralization.
Dong C; Yang H; Wang Y; Yan X; Li D; Cao Z; Ning Y; Zhang C
Biomed Pharmacother; 2020 Sep; 129():109796. PubMed ID: 32559615
[TBL] [Abstract][Full Text] [Related]
17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
18. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
[TBL] [Abstract][Full Text] [Related]
19. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Osteoporos Int; 2013 May; 24(5):1647-61. PubMed ID: 23104199
[TBL] [Abstract][Full Text] [Related]
20. Myricetin 3-
Karadeniz F; Oh JH; Jo HJ; Seo Y; Kong CS
Cells; 2021 Oct; 10(10):. PubMed ID: 34685670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
